Halozyme Therapeutics: JPMorgan raises target price to $78 from $70
HALO•JPMorgan raised its target price for Halozyme Therapeutics to $78 from $70.
Related News
UK labour market shows more signs of recovery in September, KPMG/REC survey shows
EWU•
BillionToOne CTO David Tsao sells 20,000 shares for $2.11 million
BLLN•
Hormuz transits at lowest in over two months after attacks, data shows
USO•
Samsung's AI riches lag Nvidia's money machine
SSNLF•
Tin rides the AI investment wave to a new price dimension
GLD•